178 related articles for article (PubMed ID: 15313133)
1. Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal.
Njongmeta LM; Nfon CK; Gilbert J; Makepeace BL; Tanya VN; Trees AJ
Int J Parasitol; 2004 Aug; 34(9):1069-74. PubMed ID: 15313133
[TBL] [Abstract][Full Text] [Related]
2. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
Tchakouté VL; Bronsvoort M; Tanya V; Renz A; Trees AJ
Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534
[TBL] [Abstract][Full Text] [Related]
3. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.
Trees AJ; Graham SP; Renz A; Bianco AE; Tanya V
Parasitology; 2000; 120 Suppl():S133-42. PubMed ID: 10874716
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G
Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
[TBL] [Abstract][Full Text] [Related]
5. Successful vaccination against Onchocerca ochengi infestation in cattle using live Onchocerca volvulus infective larvae.
Achukwi MD; Harnett W; Enyong P; Renz A
Parasite Immunol; 2007 Mar; 29(3):113-6. PubMed ID: 17266738
[TBL] [Abstract][Full Text] [Related]
6. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
7. Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon.
Seidenfaden R; Fischer A; Bonow I; Ekale D; Tanya V; Renz A
Trop Med Int Health; 2001 Sep; 6(9):715-25. PubMed ID: 11555439
[TBL] [Abstract][Full Text] [Related]
8. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
9. Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle.
Boussinesq M; Enyong P; Chounna-Ndongmo P; Njouendou AJ; Pion SD; Rech A; Roberge C; Gaudriault G; Wanji S
Parasite; 2020; 27():36. PubMed ID: 32420864
[TBL] [Abstract][Full Text] [Related]
10. [Molecular approaches to the control of onchocerciasis in Mexico].
Rodríguez-Pérez MA
Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
[TBL] [Abstract][Full Text] [Related]
11. Onchocerciasis control: biological research is still needed.
Boussinesq M
Parasite; 2008 Sep; 15(3):510-4. PubMed ID: 18814732
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
Soungalo T; Soumana D; Moussa S; François R
Acta Trop; 1997 Dec; 68(3):297-300. PubMed ID: 9492914
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Mbah GE; Ayiseh RB; Cho-Ngwa F
BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
[TBL] [Abstract][Full Text] [Related]
14. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With
Zhan B; Bottazzi ME; Hotez PJ; Lustigman S
Front Cell Infect Microbiol; 2022; 12():869039. PubMed ID: 35444961
[TBL] [Abstract][Full Text] [Related]
15. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
16. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.
Tchakouté VL; Graham SP; Jensen SA; Makepeace BL; Nfon CK; Njongmeta LM; Lustigman S; Enyong PA; Tanya VN; Bianco AE; Trees AJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5971-6. PubMed ID: 16585501
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
19. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Awadzi K; Boakye DA; Edwards G; Opoku NO; Attah SK; Osei-Atweneboana MY; Lazdins-Helds JK; Ardrey AE; Addy ET; Quartey BT; Ahmed K; Boatin BA; Soumbey-Alley EW
Ann Trop Med Parasitol; 2004 Apr; 98(3):231-49. PubMed ID: 15119969
[TBL] [Abstract][Full Text] [Related]
20. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
